Listening to the patient voice: Why developing new dementia treatments is everyone’s jobDeveloping life-changing treatments for dementia is a team effort that takes commitment from all involved, from charities and Share XListening to the patient voice: Why developing new dementia treatments is everyone’s jobhttps://pharmaphorum.com/views-and-analysis/listening-to-the-patient-voice-why-developing-new-dementia-treatments-is-everyones-job/
Pilot study suggests smart devices could help spot early dementiaA preliminary study run by Eli Lilly, Apple and Evidation has suggested that connected smart devices can detect Share XPilot study suggests smart devices could help spot early dementiahttps://pharmaphorum.com/news/pilot-study-suggests-smart-devices-could-help-spot-early-dementia/
Finding the big picture for Alzheimer’sThe $4m Oskar Fischer Prize hopes to catalyse a breakthrough in Alzheimer’s research by encouraging a ‘big picture’ Share XFinding the big picture for Alzheimer’shttps://pharmaphorum.com/r-d/views-analysis-r-d/finding-the-big-picture-for-alzheimers/
AI test detects early signs of dementiaA pioneering artificial intelligence (AI) computer test can help detect whether individuals are in the early stages of Share XAI test detects early signs of dementiahttps://pharmaphorum.com/news/ai-test-detects-early-signs-of-dementia/
Eisai accelerates dementia drug discovery researchEisai is launching a special dementia discovery centre to boost development of next-generation medicines targeting forms of the Share XEisai accelerates dementia drug discovery researchhttps://pharmaphorum.com/news/eisai-dementia-drug-research/
AstraZeneca and Lilly’s Alzheimer’s drug fails trialThe battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase Share XAstraZeneca and Lilly’s Alzheimer’s drug fails trialhttps://pharmaphorum.com/news/astrazeneca-lillys-alzheimers-drug/
Pfizer expands venture arm with $600m cash boostPharma giant Pfizer is injecting $600 million into its venture investment arm in a bid to ramp up Share XPfizer expands venture arm with $600m cash boosthttps://pharmaphorum.com/news/pfizer-expands-venture-arm-cash-boost/
NHS cuts clinical trial bureaucracyNHS chiefs have introduced new arrangements to fast track clinical trials and improve patients’ access to cutting-edge therapies. Share XNHS cuts clinical trial bureaucracyhttps://pharmaphorum.com/news/nhs-moves-to-cut-clinical-trials-bureaucracy/
New HQ to be flagship for UK’s dementia researchThe UK is investing more in its ‘Grand Challenge’ to tackle dementia, with a £40 million investment in Share XNew HQ to be flagship for UK’s dementia researchhttps://pharmaphorum.com/news/new-hq-flagship-uks-dementia-research/
